The Rosalind and Morris Goodman Cancer Research Centre at McGill University, located within McGill’s Life Sciences Complex, is a state-of-the-art hub for ground-breaking cancer research that has attracted and retained brilliant scientists from around the world.
Our goal is to improve our understanding of lung cancer, which in turn will lead to new therapeutic strategies and improved patient outcomes.
The McGill University Rosalind and Morris Goodman Cancer Research Centre
Established in 1978, through a bequest from Sir Mortimer B. Davis, the McGill Cancer Centre was renamed the Rosalind and Morris Goodman Cancer Research Centre (GCRC) in 2008, in honour of the major benefactors, Rosalind and Morris Goodman.
The GCRC is at the heart of Montreal’s scientific research community
This state-of-the-art Centre has energized cancer research at McGill, attracting internationally–renowned investigators. These are exciting times, with an unprecedented collaboration between clinicians and basic scientists with the shared goal of investigating the nature of cancer and metastatic disease, working together to innovate, discover and develop new treatments for cancer patients.
Morag Park, PhD
The GCRC is under the direction of
Morag Park, PhDDirector, Rosalind & Morris Goodman Cancer Research CentreDiane and Sal Guerrera Chair in Cancer GeneticsJames McGill Professor